Biogen Inc. Revenue 2007–2025
Biogen Inc. reported $9.89B of revenue for fiscal 2025. That was 2.2% higher than fiscal 2024. Compared with fiscal 2020, the change was -26.4%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $9.89B | +2.2% |
| FY 2024 | $9.68B | -1.6% |
| FY 2023 | $9.84B | -3.3% |
| FY 2022 | $10.17B | -7.4% |
| FY 2021 | $10.98B | -18.3% |
| FY 2020 | $13.44B | -6.5% |
| FY 2019 | $14.38B | +6.9% |
| FY 2018 | $13.45B | +9.6% |
| FY 2017 | $12.27B | +7.2% |
| FY 2016 | $11.45B | +6.4% |
| FY 2015 | $10.76B | +10.9% |
| FY 2014 | $9.70B | +40.0% |
| FY 2013 | $6.93B | +25.7% |
| FY 2012 | $5.52B | +9.3% |
| FY 2011 | $5.05B | +7.0% |
| FY 2010 | $4.72B | +7.7% |
| FY 2009 | $4.38B | +6.8% |
| FY 2008 | $4.10B | +29.2% |
| FY 2007 | $3.17B | — |
Source: Biogen Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BIIB 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Biogen Inc. reported $9.89B of revenue for fiscal 2025. That was 2.2% higher than fiscal 2024. Compared with fiscal 2020, the change was -26.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Biogen Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBiogen Inc. — frequently asked questions
What is Biogen Inc.'s revenue?
Biogen Inc. (BIIB) reported revenue of $9.89B for fiscal year 2025, per its SEC filings.
How has Biogen Inc.'s revenue changed over time?
Between fiscal 2007 and 2025, BIIB's revenue grew at roughly 6.5% per year (compound annual rate), from $3.17B to $9.89B.
Where does this data come from?
Figures are computed from Biogen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.